Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02296892 · ClinicalTrials.gov registry record · Phase 3
A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy
A Phase 3 study of Bronchoscopy, sponsored by Paion UK.
- Completed
- Registry status
- Phase 3
- Development phase
- 446
- Enrollment target
- 14
- Study locations
NCT02296892: Completed Phase 3 study of Bronchoscopy, sponsored by Paion UK.
NCT02296892 is a Phase 3 study of Bronchoscopy that has completed, run by Paion UK. The registered enrollment target is 446 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (42% lower). The trial reports 14 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02296892, a Phase 3 study of Bronchoscopy, has completed, sponsored by Paion UK.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 446 participants
- Enrollment target
- 14
- Study locations
Study Summary
A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open label arm for midazolam, in patients undergoing a bronchoscopy.
Primary Outcome
Success of Procedure measured by completion of bronchoscopy, no requirement for an alternative rescue sedative medication and no requirement for more than 5 doses of study medication within any 15 minute period in the blinded arms (remimazolam/placebo) or no requirement for more than 3 doses within any 12 minute window in the open-label midazolam arm.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Midazolam
- DRUG Remimazolam
Study Locations (14)
North Carolina
- Unc Division of Pulmonary and Critical Care - Chapel Hill
- Duke University - Durham
- Pinehurst Medical Clinic - Pinehurst
- Wake Forest Baptist Health - Winston-Salem
Florida
- Pab Clinical Research - Brandon
- Sun City Office - Sun City Center
South Carolina
- Medical University of South Carolina - Charleston
- S. Carolina Pharmaceutical Research - Spartanburg
Virginia
- Pulmonary Associates of Richmond - Richmond
- Virginia Commonwealth University - Richmond
Indiana
- Laporte County Institute For Clinical Research - Michigan City
Maryland
- The Johns Hopkins Center for Interventional and Pulmonary Care - Baltimore
Missouri
- Washington University School of Medicine/Barnes-Jewish Hospital - St Louis
Washington
- Multicare Institute For Research & Innovation - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-03-13 |
| Phase | Phase 3 |
What the finished NCT02296892 record still lists
NCT02296892 is an interventional study that assigns participants to a tested intervention. The registered 446 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Bronchoscopy appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02296892 lists 14 locations in 8 states (North Carolina, Florida, South Carolina).
Frequently Asked Questions
What is clinical trial NCT02296892 about?
NCT02296892 is a clinical study titled "A Phase III Study of Remimazolam in Patients Undergoing Bronchoscopy". A prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open label arm for midazolam, in patients undergoing a bronchoscopy.
What is the current status of trial NCT02296892?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 446 participants. The study started on 2015-04. Estimated completion is 2017-03-13.
What conditions does trial NCT02296892 study?
This clinical trial studies the following conditions: Bronchoscopy.
What interventions are being tested in trial NCT02296892?
The interventions under investigation include: Placebo (DRUG), Midazolam (DRUG), Remimazolam (DRUG).
Who is sponsoring clinical trial NCT02296892?
This trial is sponsored by Paion UK, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02296892 being conducted?
This trial has 14 study locations across Florida, Indiana, Maryland, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bronchoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02296892's enrollment target sits among peer trials
446 864th of 2000 higher than 1,137 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia